BridgeMD
New treatment option for Essential Tremor
Official title Algorithms for Programming DBS Systems for ET
ClinicalTrials.gov ID: NCT03984643
What this study is testing
- What it's testing
- Deep brain stimulation (DBS) targeting the Vim thalamus (ventralis intermedius nucleus) is an FDA-approved neuromodulation therapy for treating postural and action tremor in individuals with essential tremor (ET). The success of this treatment, however, is highly dependent on the ability of clinicians to identify therapeutic stimulation settings through a laborious programming process.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- diagnosis of ET
- medication-refractory tremor
- VIM-DBS implant (unilateral or bilateral)
- 7T MRI pre-operative scan under Dr. Harel's IRB (institutional review board) protocol (#1210M22183)
- Post-operative CT scan
You likely can't join if
- history of musculoskeletal disorders that affect movement of the limbs
- other significant neurological disorder
- prior history of stereotactic neurosurgery (other than VIM-DBS surgery)
- pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.